J. Kao

Ding‐Shinn Chen, J. Kao, Chun-Jen Liu, 2015, Clinical microbiology and infection : the official publication of the European Society of Clinical Microbiology and Infectious Diseases.

Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B.

Ding‐Shinn Chen, J. Kao, M. Lai, 2000, Gastroenterology.

Mother-to-infant transmission of GB virus C/hepatitis G virus: the role of high-titered maternal viremia and mode of delivery.

Ding‐Shinn Chen, J. Kao, P. Chen, 1998, The Journal of infectious diseases.

Hepatitis B genotypes and the response to interferon therapy.

Ding‐Shinn Chen, J. Kao, M. Lai, 2000, Journal of hepatology.

Higher lifetime chance of spontaneous surface antigen loss in hepatitis B carriers with genotype C infection

T. Tseng, T. Su, P. Chen, 2015, Alimentary pharmacology & therapeutics.

Long-term efficacy of ribavirin plus interferon alfa in the treatment of chronic hepatitis C.

Ding‐Shinn Chen, J. Kao, M. Lai, 1996, Gastroenterology.

Quasispecies of hepatitis C virus and genetic drift of the hypervariable region in chronic type C hepatitis.

M. Lai, P. Chen, T. H. Wang, 1995, The Journal of infectious diseases.

The clinical significance of occult hepatitis B transfusion in Taiwan – a look‐back study

T. Su, P. Chen, D. Chen, 2011, Transfusion medicine.

Effects of hepatitis B virus precore and basal core promoter mutations on the expression of viral antigens: genotype B vs C

T. Tseng, P. Chen, D. Chen, 2011, Journal of viral hepatitis.

Prolonged interferon treatment after combination interferon and ribavirin therapy in patients with chronic hepatitis C: a clinical trial of interferon relapsers and non-responders.

M. Lai, P. Chen, J. Kao, 2001, Journal of the Formosan Medical Association = Taiwan yi zhi.

Pegylated interferon α-2a versus standard interferon α-2a for treatment-naïve dialysis patients with chronic hepatitis C: a randomised study

M. Lai, P. Chen, H. Tsai, 2007, Gut.

Early interferon therapy and abortion of posttransfusion hepatitis C viral infection.

M. Lai, J. Kao, S. Yang, 1995, Journal of clinical gastroenterology.

Molecular methods of measurement of hepatitis B virus, hepatitis C virus, and human immunodeficiency virus infection: implications for occupational health practice.

Ding‐Shinn Chen, J. Kao, J. Heptonstall, 1999, Occupational and environmental medicine.

Incidence and clinical presentation of posttransfusion TT virus infection in prospectively followed transfusion recipients: emphasis on its relevance to hepatitis

J. Sheu, D. Chen, J. Kao, 2000, Transfusion.

Effects of GB virus-C/hepatitis G virus on hepatitis B and C viremia in multiple hepatitis virus infections

M. Lai, P. Chen, D. Chen, 1998, Archives of Virology.

GB virus-C/hepatitis G virus infection in an area endemic for viral hepatitis, chronic liver disease, and liver cancer.

M. Lai, P. Chen, M. Shen, 1997, Gastroenterology.

GB virus‐C/hepatitis G virus infection in prostitutes: Possible role of sexual transmission

M. Lai, P. Chen, J. Kao, 1997, Journal of medical virology.

Serotypes, genotypes and levels of hepatitis C viremia in pregnant women in Taiwan.

P. Chen, M. Mizokami, J. Kao, 1996, Journal of the Formosan Medical Association = Taiwan yi zhi.

Transient immunoglobulin M antibody response to hepatitis C virus capsid antigen in posttransfusion hepatitis C: putative serological marker for acute viral infection.

M. Lai, P. Chen, J. Sheu, 1992, Proceedings of the National Academy of Sciences of the United States of America.

Vitamin D receptor gene polymorphisms and distinct clinical phenotypes of hepatitis B carriers in Taiwan

M. Lai, P. Chen, D. Chen, 2010, Genes and Immunity.

Liver and peripheral blood mononuclear cells are not major sites for GB virus-C/hepatitis G virus replication

M. Lai, P. Chen, D. Chen, 2014, Archives of Virology.

Impact of hepatitis B virus infection on metabolic profiles and modifying factors

T. Tseng, P. Chen, D. Chen, 2012, Journal of viral hepatitis.

Fibrosis‐4 index predicts cirrhosis risk and liver‐related mortality in 2075 patients with chronic HBV infection

T. Tseng, T. Su, P. Chen, 2018, Alimentary pharmacology & therapeutics.

Immune response to a hepatitis C virus nonstructural protein in chronic hepatitis C virus infection.

P. Chen, L. Hwang, S. Tsai, 1994, Journal of hepatology.

Reactivation of hepatitis B virus in an inactive hepatitis B carrier with glucocorticoid pulse therapy.

T. Tseng, M. Lai, S. Hsieh, 2009, Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver.

Prominent proliferative response of peripheral blood mononuclear cells to a recombinant non‐structural (NS3) protein of hepatitis C virus in patients with chronic hepatitis C

M. Lai, B. Chiang, W. Chi, 1995, Clinical and experimental immunology.

Historical epidemiology of hepatitis C virus in select countries—volume 4

T. F. Rinke de Wit, V. Wong, O. Tsang, 2017, Journal of viral hepatitis.

Increased risk of hepatocellular carcinoma in chronic hepatitis C patients with new onset diabetes: a nation‐wide cohort study

S-C Fu, Y-W Huang, T-C Wang, 2015, Alimentary pharmacology & therapeutics.

GB virus C/hepatitis G virus infection in patients on continuous ambulatory peritoneal dialysis.

Ding‐Shinn Chen, J. Kao, Y. Kuo, 1998, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Hepatitis C and G Virus infections in polytransfused children

I. Hung, M. Kong, J. Kao, 1997, European Journal of Pediatrics.

Pegylated interferon α-2a plus low-dose ribavirin for the retreatment of dialysis chronic hepatitis C patients who relapsed from prior interferon monotherapy

M. Lai, P. Chen, H. Tsai, 2009, Gut.

The adjusted prevalence of hepatitis delta virus (HDV) in 25 countries and territories.

V. de Lédinghen, R. Idilman, C. Yurdaydın, 2023, Journal of hepatology.